Skip to content

COLLEGIUM PHARMACEUTICAL, INC

COLL

CIK 0001267565

← back to feed
Revenue (TTM)
$768.64M
−1.9% YoY Q1 Apr 2026
Net Income (TTM)
$60.4M
−46.2% YoY Q1 Apr 2026
EPS Diluted (TTM)
$1.65
−45.2% YoY Q1 Apr 2026
Gross Margin
58.8%
Q1 Apr 2026
Operating Margin
19.5%
Q1 Apr 2026
Net Margin
7.9%
Q1 Apr 2026
Free Cash Flow (TTM)
$200.31M
Q1 Apr 2026
Cash
$268.65M
Q1 Apr 2026
Total Debt
$14.17M
Q1 Apr 2026
Shares Outstanding
32.43M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings